Preparation method of targeted extracellular vesicles for treating drug-resistant tumors
A technology for targeting cells and tumor cells, applied in anti-tumor drugs, pharmaceutical formulations, medical preparations with non-active ingredients, etc. The effect of reducing efflux and reducing toxic side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0052] The technical solution solved by the present invention relates to a preparation method and application of a drug carrier capable of targeting and reversing tumor drug resistance EVs. The drug carrier is composed of three parts. Among them, the chemotherapeutic drug used in this study is a broad-spectrum anti-tumor drug doxorubicin hydrochloride, the main body of the carrier is EVs extracted from non-tumor cells, and the tumor targeting group is octadecylamine and A hyaluronic acid derivative formed by linking hyaluronic acid. The preparation method comprises the following steps:
[0053] Step 1. Prepare DOX-loaded EVs. EVs are derived from the culture supernatant of the non-tumor cell line HEK293T cells, and are obtained by combining ultraviolet irradiation and co-stimulation with drug DOX;
[0054] Step 2, preparing hyaluronic acid derivatives targeting CD44;
[0055] Step 3, modifying the hyaluronic acid derivatives targeting CD44 on the surface of DOX-loaded EVs. ...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com